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Abstract
Background: Milk exosomes are a rich source of microRNAs (miRNAs) that are protected from degradation. Ingestion
of milk and subsequent absorption of miRNAs into recipient cells by endocytosis may play a role in the regulation of
neonatal innate and adaptive immunity. In contrast, the miRNA content of milk exosomes may also be indicative of a
lactating animal’s health; whereby, the presence or absence of specific miRNAs could serve as biomarkers for early
detection of bacterial infection that can lead to mastitis. In the present study, we therefore analyzed and compared
miRNA expression profiles of milk exosomes from four Holstein cows obtained during mid-lactation prior to and after
infection (48 h) of the mammary gland with Staphylococcus aureus.
Methods: Milk exosomes, purified from control and S. aureus infected cows, were extracted for RNA. Following
preparation indexed libraries from both groups the samples were subjected to next generation sequencing.
Results: Next generation sequencing of eight, unpooled small RNA libraries derived from milk exosomes produced
about 60.5 million high-quality, bovine-specific sequence reads for comparison of miRNA expression between treatments.
Sequence identity analysis showed the miRNAs make up about 13 % of the average RNA content of these exosomes.
Although 417 known bovine miRNAs were identified, miRNAs represented the least diverse class of RNA accounting for
only 1 % of all unique sequences. The 20 most prevalent unique sequences within this class accounted for about 90 % of
the total miRNA-associated reads across samples. Non-annotated, unique reads provided evidence for another 303
previously unknown bovine miRNAs. Expression analyses found 14 known bovine microRNAs significantly differed
in frequency between exosomes from infected and control animals.
Conclusions: Our survey of miRNA expression from uninfected milk exosomes and those produced in response to
infection provides new and comprehensive information supporting a role for delivery into milk of specific miRNAs
involved in immune response. In particular, bta-miR-142-5p, and −223 are potential biomarkers for early detection
of bacterial infection of the mammary gland. Additionally, 22 mammary-expressed genes involved in regulation of
host immune processes and response to inflammation were identified as potential binding targets of the differentially
expressed miRNAs.
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Background
MicroRNAs (miRNAs) are a class of endogenous non-
coding small RNA molecules, typically 22 nucleotides in
length, which bind primarily to the 3'UTR of target
mRNAs to repress translation and/or accelerate the
decay [1] of up to 30 % of all expressed transcripts [2].
Numerous studies have found roles for miRNAs in regu-
lation of gene expression for important biological pro-
cesses including cellular proliferation and differentiation,
tissue development, and immune response. Of interest
for our study, miRNAs help regulate the development of
immune cells and modulate the innate and adaptive im-
mune responses [3]. Some specific examples include the
role of miR-150 in inhibiting synthesis of the transcrip-
tion factor c-Myb to help regulate B-cell differentiation
[4], and miR-126 targeting of insulin regulatory subunit-
1 transcripts to positively control the fate of B-cells [5].
Similarly, miR-146a functions as a negative regulator of
TNF receptor-associated factor 6 and Interleukin-1
receptor-associated kinase 1 transcripts during and/or
after the innate immune system responds to a bacterial
infection [6]. These examples demonstrate how micro-
RNAs can exert some regulatory control of the immune
system within a cell. More recent studies have shown that
extracellular miRNAs stably present in body fluids through
encapsulation into exosomes or microvesicles; may also
play a significant role in intercellular communication dur-
ing an immune response [7–9]. Therefore, the presence of
specific miRNAs in exosomes may be indicative of various
pathological conditions and provide biomarkers for detec-
tion of certain disease conditions [7].
Despite the recognized importance of miRNAs in host
immune response to disease in humans and mice, their
comparative roles in regulating the immune response of
livestock are still in preliminary stages of study. Expression
surveys of bovine miRNAs have been reported for em-
bryos [10], muscle [11], adipose [12, 13], mammary gland
[13], testicular and ovarian tissues [14–16], and various tis-
sues involved in immune response [17]; but none of these
reports have interrogated miRNA expression changes in
response to infection. More recently, Lawless and col-
leagues reported two studies surveying miRNA expres-
sion changes in response to bacterial infection of a
bovine cell line [18] and circulating monocytes from
blood and milk [19]. In the latter report, bovine specific
miRNAs were identified as amplifiers of monocyte
inflammatory response networks and repressors of sev-
eral metabolic pathways in response to Staphylococcus
uberis (S. uberis) infection of the mammary gland.
Based on these findings and the hypothesis that exo-
somes may contain specific miRNAs indicative of infection
means that characterizing the miRNA profile of bovine
milk exosomes could provide further understanding of host
immune response signaling during lactation. It is well
known that human milk is the most essential nutritional
source for infant health during postnatal development [20],
containing nutrients that closely match infant requirements
for brain development, growth, and a healthy immune sys-
tem [21, 22]. In the past decade, many immune-related
substances like secretory immunoglobulins, leukocytes, and
antimicrobial factors such as lysozyme, lactoferrin, and
oligosaccharides have been detected in milk [23]. More
specific analyses of the exosome component of human milk
found abundant immune-related proteins [24] as well as
miRNAs [8, 9]. The presence of miRNAs has also been
confirmed from cursory surveys of bovine [25–27] and
porcine milk [28]. Taken together, the immune-related fac-
tors in milk exosomes could impart some pathogen resist-
ance to the newborns lacking a fully developed immune
system [29]. Some miRNAs may play a role in these effects
[25, 26], since there is evidence that exosome miRNAs are
readily absorbed within the neonate digestive tract after in-
gestion of milk [30].
Thus, the goal of our study was to comprehensively sur-
vey by deep sequencing the miRNA content of bovine
milk exosomes derived from both healthy and infected
mammary glands, and then attempt to identify if host re-
sponse to infection significantly changes the content of
specific miRNAs in exosomes. We chose to harvest exo-
somes from lactating Holstein cows challenged with
Staphylococcus aureus (S. aureus); because Holsteins are
the primary source of milk-related products consumed by
humans globally, and S. aureus is a leading causative agent
of bovine mastitis. Furthermore, identification of differen-
tially expressed exosome miRNAs in this infection model
serve as potential molecular targets for development of
biomarkers assays to provide early detection of sub-
clinical mastitis.
Results and discussion
Sequence analysis of milk exosome miRNAs
Next generation sequence analysis of the eight small RNA
libraries derived from milk exosomes prior to (N = 4
control) and 48 h post S. aureus infection (N = 4 infected)
yielded more than 76.4 million 36 nt sequences. After fil-
tering, approximately 17.7 and 54.3 million high-quality
sequence reads from the control and infected libraries
were available for reference genome alignment, respect-
ively (Additional file 1). The unbalanced read results be-
tween treatments was due to an intentional increase of
sequencing coverage of the infection sample 2 library,
which showed the rate of unique sequence discovery was
reduced with additional depth of sequencing but still com-
parable to the other libraries with fewer sequence reads
(Additional file 1 – last row). In total, all reads represented
about 1.8 million unique sequences, and SOAP alignment
[31] to the bosTau6 reference genome assembly [32] re-
sulted filtered this set of unique sequences down to
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747,169 bovine specific sequences corresponding to about
60.5 million total sequences (84 % of total) for further ana-
lyses. Consistent with a previous report [17], the relatively
high sequence depth (avg. of 80 reads per unique se-
quence) and multiple, unpooled samples (N = 8) provided
enough replication for bona fide discovery of potentially
novel miRNAs expressed from the bovine genome.
Sequence identities were assigned to the 747,169 unique
sequences by alignments to Rfam and bovine-specific se-
quences within mirBAse, Repeat and Reference mRNA da-
tabases. The average RNA content of milk exosomes based
on alignments of mapped, annotated reads was approxi-
mately: 1) 58 % other non-coding RNA (mostly tRNA with
some rRNA, snRNA and snoRNA – Additional file 1B), 2)
13 % known bovine miRNA, 3) 23 % repetitive sequences,
4) 1 % mRNA (unspliced and mature), and 5) 4 % non-
annotated sequence (Additional file 1). Comparing the ra-
tio of total sequence reads to unique sequences for each
identity category revealed miRNA associated sequences
were the least diverse class of RNA present in milk exo-
somes with mRNA and other non-coding RNA associ-
ated sequences having 500- and 50-fold more observed
diversity, respectively. Because the purpose of this study
was to characterize miRNA-associated sequences and
attempts to identify bovine snoRNA and piRNA iden-
tities were hampered by lack of annotation for the bo-
vine reference genome, none of the other categories of
sequence were analyzed further. However, non-miRNA
sequence data is available for future analyses through
GEO accession GSE55144.
In order to examine the potential miRNA content of
milk exosomes more deeply, the 4732 miRNA-associated
unique sequences (<1 % of all unique RNA sequences)
were clustered into homolog groups based on annotation
of best match to miRBAse. Using SOAP and mirDeep2
[33] methods, identities of unique sequences could be
assigned to 337 miRNA homolog groups corresponding to
376 miRNA loci and 411 miRNA homologs corresponding
to 452 miRNA loci, respectively (Additional file 2A). The
union of these two results yielded 417 known miRNAs
corresponding to over 53 % of known bovine miRNAs in
miRBase Release 19.
The reduction of 4732 unique sequences to a set of
417 homologs is most likely attributable to the presence
of isomiRs, which are heterogeneous variants of canon-
ical miRNA species [34]. This finding was supported by
variation in sequence read length (1–5 nt) for some
unique sequence alignments within a homolog groups
(Additional file 3). However, miRNA length distribution
analysis (Fig. 1) showed the highest count of miRNA-
associated reads was 22 nt in length (40.14 %), and the
majority of unique sequences reads ranged within the
expected length of 21–23 nt. Interestingly, a significant
portion of unique reads was also present in the length
ranging from 18–20 nt. This result requires further in-
vestigation, but the length variation may be attributed to
enzyme modifications and imprecise processing of pri-
mary or precursor miRNAs by Drosha and Dicer en-
zymes, such as RNA editing in miRNA-mediated gene
silencing [35], 3'-editing [36], and degradation of micro-
RNAs by a family of exonucleases [37].
Looking at diversity within the 417 miRNA homolog
groups, the number of total sequences representing iso-
miRs ranged from one to hundreds. As expected, the most
Fig. 1 Distribution by length of mapped sequence reads. The distribution of mapped sequence reads from milk exosomes matching known bovine
miRNAs found in miRBase binned by length (nt) and shown by percentage of unique (red) and total (blue) sequence read counts
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highly expressed isomiR usually corresponded to the bo-
vine reference sequence in miRBase (Additional file 3). A
total of 201 miRNAs were found to have at least one iso-
miR expressed at a level of ≥10 sequence reads and more
than 1432 different isomiRs were identified in total. The
group designated bta-mir-2904 had the highest diversity of
isomiRs at a level of ≥10 sequence reads with counts of
106 variants at the 5' end and 102 variants at the 3' end.
The presence of such miRNAs variants was previously sug-
gested to be cell type specific, have functional differences,
and vary in their response to biological stimuli [38]. In our
dataset, about 38 % of the isomiRs were variant at the 5'
end, which should change the seed sequence (2–7 nt at the
5' end), and thereby effect changes in target mRNA and
possibly miRNA function [39]. Overall, these results fully
illustrated that miRNA diversity in exosomes is greatly ex-
tended through the presence of multiple isomiRs, which is
a result that cannot be elucidated by real-time PCR or
microarray expression analyses.
After accounting for isomiRs, we evaluated the overall
distribution of miRNA diversity based on homolog group-
ings. The 15 most prevalent miRNAs accounted for be-
tween 76-88 % of the total normalized sequence reads
depending on analysis method, while the members of this
list were nearly conserved between methods (Additional
file 2B). Furthermore, eight of these miRNAs (miR-30a-
5p, −148a, 22-3p, −141, −186, −26a, −181a and -27b)
shared common ranking as top 10 expressed miRNAs
when parsing the sequence data based on treatment (con-
trol and infected exosomes), suggesting these miRNAs
could be important nutritional components of milk. Re-
cently, similar miRNAs were found by sequencing of lac-
tating caprine mammary gland [40, 41], bovine mammary
epithelial cells [18], and porcine [28] and human [9] milk.
In the latter two studies; miR-30a, −148a, −141 and -27b
were also represented as the top 10 miRNAs. Previous
miRNA expression studies using bovine mammary tissue
[42, 43] or milk [26] also found miR-148a and -181a as sig-
nificantly elevated during lactation, respectively. However,
most of the miRNAs reported as elevated in mammary tis-
sue during ovine and bovine lactation do not match the
most prevalent miRNAs from exosomes [44]. Some of
these differences could be because previous studies only
profiled expression for a pre-selected subset of miRNAs,
which did not overlap with our Top 10 list. However, miR-
148a-3p, which accounted for ~18.6 % of the total miRNA
associated sequence reads, has previously been suggested
as a nutritional biomarker corresponding to the protein
content of various bovine-derived milk products [26].
Interestingly, feeding studies that have shown exogenous
plant [45] or milk [30] miRNAs can be found in the sera
and tissues and influence regulation of target genes in re-
cipient animals. Combining the findings of these reports
with the pleiotropic roles of the 10 most prevalent miRNAs
in our study suggests the enrichment of specific miRNAs
derived from mammary secretory cells may also influence
development of the immune system of neonates. Specific-
ally, the miR-30a-5p and -30d (members of the miR-30
family) are known to be involved in regulation of autoph-
agy in cancer progression and treatment by suppressing
the expression of beclin 1 [46] and also cellular invasion
and immunosuppression by targeting GalNAc transferase
GALNT7 to increase synthesis of the immunosuppressive
cytokine interleukin-10 [47]. Also widely studied for pos-
sible involvement in tumor progression, miR-148-3p has
been shown to directly target the TGIF2 gene in ovarian
cancer [48], the drug metabolizing PXR gene in human
cancer metastasis [49], and CAND1 expression in human
prostate cancer to promote prostate cell growth [50]. In
the case of miR-27b, mRNA stability of PPARgamma is
destabilized, which is often associated with chronic inflam-
matory diseases provoked by an immune response [51].
MiR-27b has also been found to be degraded by a viral
transcript in lytic murine cytomegalovirus (MCMV) infec-
tion [52], further highlighting its role in immunity. Another
prevalent milk miRNA, miR-181a, regulates T-cell selec-
tion by altering sensitivity to peptide antigens, which is
partly achieved through the down regulation of multiple
phosphatases that act as negative regulators of T cell recep-
tor signaling [53]. Additional supporting evidence includes
the roles of plasma miR-141 as a biomarker for colon can-
cers [54], miR-186 as a tumor-suppressor for the develop-
ment and progression of lung adenocarcinoma [55], miR-
26a in miRNA biogenesis to target Lin28B and Zcchc11 as
a suppression mechanism for tumor growth and metastasis
[56], and miR-22 targeting of estrogen receptor α mRNA
to inhibit estrogen signaling associated with some forms of
breast cancer [57]. Finally, miR-191, a well characterized
oncogenesis-related miRNA, is a biomarker of colorectal
cancer [58], primary effusion lymphoma [59], and hepato-
cellular carcinoma [60]. Even though there is compelling
evidence that the most prevalent miRNAs in our study
could potentially exert an influence on immune response,
the specific functional roles of each miRNA needs further
detailed investigations to obtain a thorough under-
standing of the specific targets and mechanistic effects of
consumption of miRNA-loaded bovine milk exosomes by
a recipient animal. This is especially relevant considering
that effects of microRNA consumption are still not well
validated [61].
Novel miRNA discovery
After assignment of sequence identities by various
alignments (Additional file 1), nearly 38 % of all unique
sequences had no identity or were considered non-
annotated. A mireap analysis [62] of these sequences
identified 562 potentially novel bovine miRNAs corre-
sponding to 593 genomic loci (Additional file 4A).
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Interestingly, the total read counts for each of these
potential miRNAs were much lower on average than
for those matching known bovine miRs already present
in miRBase. For instance, there were only 57 unique se-
quences with a total read count >100, and many of our
initial novel miRNAs (N = 259) had read counts <10.
Because known miRNAs use as little as 6–8 nucleotides
on the 5' end to recognize target mRNAs [63, 64], the se-
quence of this seed region for the potentially novel miR-
NAs was compared to those seed regions found among
25,141 miRNAs in miRBase. A total 88.6 % of novel miR-
NAs had a seed sequence identical to those reported for
known mature miRNAs, and this sequence conservation
supports functionality for many of the miRNAs predicted
by mireap analysis of non-annotated reads.
After removing the 259 unique sequences with <10
total reads counts, the remaining 303 unique sequences
were also aligned to miRBase using BLAST. Only three
unique sequences had 100 % identity with known miRNAs
found exclusively in other species (eca-miR-1842, dre-miR-
1388-5p, mmu-miR-219c-3p). In addition, 24 and 23
unique non-annotated sequences had significant homology
with the bta-mir-2285 and bta-mir-2284 families, respect-
ively (Additional file 4B). These results were consistent
with a previous report that mir-2285 and −2284 families
had possibly over 40 members spanning the entire bovine
genome [65]. Although we are confident these analyses
identified previously undiscovered bovine miRNAs, none
of these sequences were used for the differential expression
analyses between exosomes from control and infected milk.
Differentially expressed miRNAs in response to S. aureus
infection
Compared to previous NGS studies investigating the milk
miRNAs in bovine [26], porcine [28] and human [9], we
generated sequence reads from unpooled miRNA libraries
corresponding to individual animal replicates under differ-
ent treatment (pre- and post-infection). This allowed
exploration of statistically significant changes in miRNA
content of milk exosomes in early response to S. aureus
infection of the mammary gland. A separation of control
(pre-infection) from infected samples was confirmed by
principal component analysis (PCA) of the normalized se-
quence reads representing the 417 miRNA homolog clus-
ters (Fig. 2). PC1 explained 55.17 % of the overall miRNA
expression variability, whereas PC2 explained 28.51 % of
the variability.
The primary differential expression (DE) analysis was
done using EdgeR and compared expression values of
the unique miRNAs as determined by miRDeep2
normalization (Additional file 5). This approach de-
tected a total of 14 DE miRNAs (Table 1). Heatmap
analysis of these 14 DE microRNAs shows the cluster-
ing of infected from control samples (Fig. 3), ageing
with the infection challenge statistics of these animals
(Additional file 6).
As a comparison to the EdgeR analysis, a differential
expression analysis was also done by SOAP (Additional
file 7), and six common miRNAs (bta-miR-101, −142-
5p, −183, −2285 g-3p, −223 and -99a-5p) with
Fig. 2 Principal component analysis of mapped reads by animal.
Principal component analysis of the mapped sequence reads matching
known bovine miRNAs from the eight individual libraries. Control
represents sequences from non-infected milk exosome libraries and
Infection represents those from infected quarters of the same animals
48 h post-infection
Table 1 Known Bovine miRNAs with Significant Changes in
Exosome Content in Response to Infection
miRNA name P Valuea Change Relative to Control Fold Change
bta-miR-142-5p 8.86E-08c UP 263
bta-miR-296-5p 6.70E-05 DOWN NDb
bta-miR-223 1.39E-04c UP NDb
bta-miR-1246 1.23E-03 UP 196
bta-miR-183 2.31E-03c UP 6
bta-miR-502b 8.84E-03 DOWN −13
bta-miR-378b 1.60E-02 DOWN −10
bta-miR-2285 g-3p 1.73E-02c DOWN −4
bta-miR-99a-5p 1.93E-02c UP 3
bta-miR-181b 2.25E-02 DOWN −3
bta-miR-101 2.73E-02c DOWN −3
bta-miR-10a 2.87E-02 UP 15
bta-miR-99b 3.66E-02 UP 3
bta-miR-2419-5p 4.86E-02 DOWN −3
aP Value Determined by EdgeR Analysis of Upper Quartile Normalized
Sequence Reads corresponding to Bovine miRNA Homolog Groups
bbta-miR-296-5p was not present in infection samples and bta-miR-223 was
not present in control samples
cAlso significant by SOAP analysis
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differential presence in milk exosomes between unin-
fected and infected animals were identified (Table 1).
Comparing our DE miRNA results from milk to previ-
ously reported changes in bovine mammary-derived
miRNA expression revealed observations in support of
our findings. For example, we detected increases of bta-
miR-142-5p and −223 in milk exosomes 48 h post-
infection, while both lactating mammary epithelium
[66] and bovine monocytes [19] under infection chal-
lenge with S. uberis also were found to increase levels of
miR-223. Other reports surveying bovine milk [26, 27]
found higher levels of miR-223 in colostrum possibly in
support of increased immunity for early neonates or the
mammary gland during a period of higher susceptibility
(post-partum) to bacterial infection. Lawless and colleagues
also found significant increases in miR-142-5p in mam-
mary monocytes post-infection [19]. The cellular source
of increases in our results, mammary epithelium or
monocytes or both, remains to be determined; however,
the lower levels of relative expression in comparison to
the most prevalent miRNAs in exosomes suggests only
a subset of cells responding to infection are contribut-
ing these RNAs to milk. The decreases in -15b, and
-193a-5p found only using SOAP analysis are supported
by similar findings in mammary epithelium [66] and
monocytes [19], respectively. In contrast, we did not
find any expression of bta-miR-2898, which was previ-
ously found to be upregulated in response to bacterial
infection of mammary gland, where a potential role as a
modulator of immune response was supported through
differential regulation of A2M transcript binding [67].
Regarding the roles of these miRNAs in immune
response, a previous study demonstrated elevated miR-142
in systemic lupus erythematosus patients compared to
healthy controls [68]. MiR-142 has also been shown to be
abundant in T cells [69], which implied its role as an
immune-relevant miRNA while its function remains un-
clear. On the other hand, miR-223 has a potential role in
balancing metabolism and immune response during infec-
tion [19], as previous bioinformatic analysis provides
support for its importance in down-regulating lipid metab-
olism [66]; a process very important during milk produc-
tion. Beyond its role in response to mammary infection in
cattle, miR-223 was also recently reported to regulate gran-
ulopoiesis [70]. In spite of the limited knowledge of milk
enriched miRNAs in response to bacterial infection, our
results present significant information about highly ex-
pressed miRNAs in bovine milk exosomes from healthy
and infected animals, and provides specific miRNAs that
can be targeted for biomarker development as a potential
means for early diagnostic detection of sub-clinical mastitis.
Prediction and analysis of target genes
A total of 7961 unique genes were predicted by RNAhybrid
to be targeted based by the six DE miRNAs found in
common between both analysis methods (bta-miR-101,
Fig. 3 Heatmap of differentially expressed miRNA. Heatmap of 14 differentially expressed miRNAs (P < 0.05) between infected and non-infected
as determined by miRDeep2 analysis of normalized sequence reads corresponding to known bovine miRNAs. Note: IN = Infected sample; C = Control
or non-infected sample
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−142-5p, −183, −2285 g-3p, −223 and -99a-5p). Of these,
4511 genes were predicted to be targeted by up-regulated
miRNAs; 1500 were targeted by down-regulated miRNAs;
and 1950 were targeted by both up and down-regulated
miRNAs (Additional file 8). Because many of these target
mRNAs may not actually be expressed during lactation,
we filtered our candidate list of 7961 genes for mammary
specific genes by only selecting those encoding proteins
identified in previous reports [71, 72]. From this reduced
list of 2350 genes encoding mammary derived protein
found in exosomes, a total of 219 overlapping target genes
were identified (Additional file 9A). DAVID analysis re-
sults showed 11 Biological Processes GO terms for 22
genes, which were significantly related to host immune
processes and inflammation (Additional file 9B). We
therefore hypothesized that differentially expressed miR-
NAs can target sequences in these 22 genes to regulate
the immune responses with S. aureus infection. This new
knowledge of milk miRNA expression between healthy
cows and cows with mastitis will provide information im-
portant for the immune function in the mammary gland.
Conclusions
In conclusion, we have comprehensively analyzed the
RNA content of milk exosomes from infected and unin-
fected animals using next generation sequencing to iden-
tify 417 known bovine miRNAs and 303 novel candidate
miRNAs. Expression analyses identified six miRNAs that
were significantly differentially present in exosomes in re-
sponse to bacterial infection of the mammary gland, and
provided two promising targets in bta-miR-142a and −223
for biomarker development of bacterial infection. Overall,
this study expands the repertoire of bovine miRNAs and
provides some specificity for the most prevalent miRNAs




The United States Department of Agriculture (USDA),
Agricultural Research Service (ARS), National Animal
Disease Center (NADC) animal care and use committee
approved all experimental animal procedures used in this
study. No human subjects or data were used in this study.
Milk exosomes were derived from Holstein cows (N = 4)
housed at the NADC. Prior to infection all cows were
healthy, and milk was confirmed free of bacteria. The exo-
some isolation methods and S. aureus challenge param-
eters were described previously for a proteome study of
milk exosomes [72]. Briefly, control milk was aseptically
collected from each quarter during mid-lactation
(90 days in milk) and infected samples were collected
48 h post-infection from the matching quarter infused
with approximately 400 colony forming units (CFU) of
S. aureus (Newbolt strain) suspended in 10 ml of PBS.
The crude exosomes were purified by sucrose gradient
centrifugation and filtration [71]. The S. aureus infec-
tions were confirmed as previously described [72] and
are summarized in Additional file 6.
Small RNA library sequence analysis
Total RNA was extracted from pelleted exosomes
using the manufacturer’s protocol for TRIzol® Reagent
(Life Technologies, Carlsbad, CA, USA). Presence of
post-extraction RNA was assessed by using a RNA 6000
pico assay run an Agilent Bioanalyzer (Agilent Technolo-
gies, Santa Clara, CA, USA). Eight Illumina-indexed librar-
ies (four representing milk exosomes prior to infection and
four from S. aureus infected samples 48 h post-infection)
were constructed with an Illumina TruSeq small RNA
library kit according to the manufacturers’ protocol
(Illumina, Inc., San Diego, CA), which included size
selection of the final library amplicons. All small RNA
libraries were subjected to quality and purity check
using Agilent’s 7500 DNA Bioanalyzer assay (Agilent
Technologies, Santa Clara, CA, USA) and Qubit Fluoro-
metric Quantitation (Life Technologies, Carlsbad, CA,
USA). Quantitated libraries were diluted to 1 nM con-
centration and equal volumes were mixed for multiplex
sequence analysis, and diluted to a final of 5 uM
concentration for clustering on a Truseq flow-cell prior
to analysis by single end sequencing (40 nt) on Illumina
Genome Analyzer II.
Preliminary quality control analysis of the eight Fastq
files generated using the FastQC package v0.10.0 [73]
aimed to filter low quality short reads, remove poly A, trim
3'/5' adapter, and format into non-redundant Fasta files.
Cutadapt v1.3 [74] was implemented to trim 3'/5' adaptor
sequences, and reads less than 18 nt were removed from
the dataset for analysis. The occurrence of each unique
sequence read was tallied (Additional file 1). All unique se-
quence tags that passed through the above filtering criteria
were mapped onto the bosTau6 version of the bovine ref-
erence genome assembly [32] using the SOAP algorithm
[31] allowing up to 3 bp mismatches to detect isomiRs.
Uniquely mapped tag sequences were aligned against Rfam
v11.0, bovine miRNAs in miRBase v19.0, repeat database
produced by RepeatMasker [75] and the coding genes of
the reference genome [76]. Based on the annotation of
the best matches, these unique sequences were classi-
fied as other non-coding RNA, known miRNA, genomic
repeats or degradation products of mRNA. Sequences
that mapped to the reference genome, but did not fit
any of the above annotation categories were classified as
‘non-annotated’ reads.
A second method of data processing, named “miRDeep2-
method” [29], was also used with some improvements.
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Under this method, Trimmed reads were then further
filtered using Sickle [77] to remove low quality sequences
with quality values <20. Reads that successfully passed
filtering were aligned to the bovine miRBase v19.0 using
miRDeep v2.0.0.5 with a Perl script “quantifier.pl”.
All miRNAseq data was submitted to the NCBI Gene
Expression Omnibus (GEO) database with the experiment
series accession number GSE55144.
miRNA expression analysis
To compare differentially expressed miRNAs between
multiple samples through the miRDeep2-method, read
count of each identified miRNA was normalized be-
tween libraries using upper-quartile normalization [78].
The R v3.0.2 Bioconductor package EdgeR v2.4.6 [79]
was used to identify statistically differentially expressed
miRNAs. Those miRNAs expressed at least once in con-
trol or infected samples were considered for further ana-
lysis. Differentially expressed miRNAs were defined as
having a Benjamini and Hochberg corrected P value <0.05
[80]. The heat map of the differentially expressed miRNAs
was generated using Cimminer [81] under the Canberra
and Ward settings for Distance Method and Cluster Algo-
rithm settings, respectively.
As a secondary validation analysis using SOAP [31],
count data was individually normalized across 8 libraries
using the formula: normalized expression (NE) = actual
miRNA count/total count of clean reads × 106 using
SOAP. P-values were calculated from the normalized ex-
pression [82] in each replicate group compared between
control and infected samples by:
P xjyð Þ ¼ N 2
N1
 y xþ yð Þ!
x!y! 1þ N2N1
  xþyþ1ð Þ








where x and y represent normalized expression levels,
and the N1 and N2 represented total sequence read
count for a given miRNA from the infected and control
small RNA libraries, respectively. A specific miRNA was
deemed to be significantly differentially expressed when
the P-value was <0.01, and there was at least a 2-fold
change in normalized sequence counts across all four
replicates. The significant differentially expressed miR-
NAs identified by both SOAP and miRDeep2 approaches
were selected for further target prediction analysis.
Novel miRNA prediction
To investigate discovery of potentially novel miRNAs, all
unmapped reads from the “SOAP-method” were run
through Mireap [62], a prediction software that explores
secondary structure characteristic, the Dicer cleavage site
and the minimum free energy of input sequence reads.
The following criteria [83] were used for identifying po-
tentially novel miRNAs from unique sequence reads: 1)
aligned to non-annotated regions of a bovine reference
genome, 2) folded into hairpin secondary structures (with
flanking sequence added) and unique sequence read was
present in one arm of miRNA precursor, 3) demonstrated
a 2 nt 3'-overhang between the sequence read (presumed
miRNA mature strand) and its complementary strand
(miRNA*), 4) folded hairpin miRNA precursors lacked
large internal loops or bulges, 5) had a free energy of
hybridization ≤ −18 kcal/mol as a folded hairpin structure,
6) carried a higher minimal free energy indexes (MFEIs)
as a predicted precursor miRNA than other different types
of RNAs.
Target predictions
Differentially expressed miRNAs from the exosomes were
further analyzed to predict potential regulatory target tran-
scripts. Bos taurus mRNA sequences were downloaded
from the NCBI database and input into RNAhybrid soft-
ware [84] based on a series of rules: 1) no mismatch
present between base pairs 1–9 on the 5' end of the
miRNA/target RNA duplex, 2) G:U pairing was permitted
for up to 3 bases. In addition, we also used Reinhardt et
al.’s data [27] gained by analysis of bovine milk exosome
proteome infected with S. aureus to narrow down the pool
of potential targets predicted by computational analysis.
Only target sites which were identified by the two ap-
proaches were further considered. Using DAVID Bioinfor-
matics Resources 6.7 [85] only predicted targets which
were identified by both computational and experimental
analysis from infected exosomes were submitted to David
Gene Ontology (GO) terms.
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